Dr. Sharon Wyatt Moore, MD, MBA, MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1241 Volunteer Pkwy, Suite 950, Bristol, TN 37620 Phone: 423-968-9533 Fax: 423-968-3567 |
Robert A Mueller, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Blvd, Suite 150 W, Bristol, TN 37620 Phone: 423-844-3360 |
News Archive
Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.
Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced today that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area.
As part of National Condom Week (Feb. 14 - Feb. 21), Planned Parenthood of the Great Northwest distributed 55,000 condoms throughout western Washington. The condom packaging contained QR codes, barcodes that can be scanned by smart phones which direct users to a mobile website. The website is www.WhereDidYouWearIt.com, a geo-location service website that allows users to "check-in" their safe sex activity. The site is intended to promote healthy sexuality and encourage social media users, to "be proud to wear protection," Planned Parenthood said in a written statement. "Wheredidyouwearit.com is like Foursquare for people who don't want a sexually transmitted infection," PPGNW said on its website.
Nearly half of all adults over 20 will experience at least one lower urinary tract symptom by 2018 - an estimated 2.3 billion people and a worldwide increase of 18% in just one decade - according to research in the October issue of the urology journal BJUI.
New Zealand's Ministry of Health has released research that shows Primary Health Organisation (PHO) family doctor visits have become more affordable for half the country's population.
› Verified 5 days ago